Monica's practice focuses on the representation of high-growth emerging technology and life sciences companies as well as venture capital and other investors on various corporate and securities transactions across Asia and the US, including venture capital financing, private equity investments, mergers and acquisitions, foreign direct investment and public offerings. She also has broad experience in a wide variety of projects and advising clients on cross-border commercial transactions, including company formations, spin-offs, private and public financings, mergers and acquisitions, joint venture, licensing and other strategic transactions, employee equity incentives, corporate governance matters, manufacturing and distribution arrangements. Monica counsels companies from start-ups to well established companies in a variety of industries, including life sciences, biotechnology, healthcare and medical devices, fintech, ecommerce, software, edtech and digital health.

Download full bio 


  • InxMed Raises $50 Million Series B 

  • EpimAb Biotherapeutics Raises $120 Million Series C 

  • Crown Bioscience Enters Merger Agreement With JSR Corporation 


  • New York University School of Law

  • East China University of Political Science and Law
    LLB, International Economic Law
    with honors

Admissions & Credentials

New York